Comparisons
Cagrilintide With Retatrutide or Tirzepatide
Cagrilintide acts on amylin and calcitonin receptors, not incretin receptors. Why it is paired with GLP-1 agonists, what CagriSema showed, and blend handling.
Tag: Retatrutide
Comparisons
Mazdutide and Survodutide vs Retatrutide: Dual vs Triple
Mazdutide and survodutide are GLP-1/glucagon dual agonists; retatrutide adds the GIP receptor. Structures, phase 2 and 3 endpoints, and what the gap implies.
Comparisons
Tesamorelin vs Retatrutide, Tirzepatide and MOTS-c
Tesamorelin works through the GH axis; incretin peptides through GIP, GLP-1 and glucagon receptors; MOTS-c through AMPK. Four different mechanisms compared.
Comparisons
Orforglipron vs Retatrutide: Small Molecule or Peptide
Orforglipron is a non-peptide GLP-1 receptor agonist; retatrutide is a triple-agonist peptide. The structural contrast and what it changes.
Comparisons
Sermorelin vs GLP-1 and Retatrutide: Two Axes
Sermorelin acts on the pituitary growth hormone axis; GLP-1 and retatrutide act on gut hormone receptors. The comparison is between systems.
Comparisons
Eloralintide vs Incretin Peptides: A Different Receptor
Eloralintide is an amylin receptor agonist, not an incretin analogue. Why that makes comparisons with retatrutide and tirzepatide awkward.
Comparisons
MOTS-c vs Retatrutide: Mitochondrial vs Receptor
MOTS-c is a mitochondrially encoded peptide with no established receptor; retatrutide is a triple incretin receptor agonist. Two different sciences.
Peptide Profiles
What Is Retatrutide? The Triple Agonist Peptide Explained
Retatrutide (LY3437943) is one peptide that activates GIP, GLP-1 and glucagon receptors. Its pharmacology, half-life and trial results.
Research Reviews
Retatrutide Half-Life: What Phase 1 Data Show
Retatrutide's half-life in humans is about 6 days in a phase 1b trial. How it was measured, why it is so long, and what it means for stability.
Comparisons
Retatrutide vs Semaglutide: One Receptor or Three
Semaglutide is a selective GLP-1 receptor agonist; retatrutide activates GIP, GLP-1 and glucagon receptors. Structure, half-life and trial endpoints compared.
Comparisons
Retatrutide vs Tirzepatide: Receptors, PK and Trial Data
Retatrutide adds glucagon receptor activity to tirzepatide's GIP/GLP-1 agonism. Receptors, half-life, status and trial endpoints compared.
Lab Handling
How to Reconstitute Retatrutide: Lab Method and Math
Reconstituting lyophilized retatrutide for research: solvent choice for a lipidated peptide, concentration tables for 5–60 mg vials, mixing and storage.